Answer
Yes, rhabdomyolysis has been identified during post-approval use of nelarabine, including spontaneous case reports and serious adverse events from ongoing studies.
Sources for this answer
- Atriance 5 mg/ml solution for infusionSandoz Limited · emc · SmPC §4.8 Undesirable effects · Version 18Document updated
Sources checked